BioAge Labs (NASDAQ: BIOA) emerged as a standout performer in the weight-loss drug sector last week, with its stock skyrocketing 46.6% in the week ending October 25. The rally was primarily ...

Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...

The United Kingdom's healthcare regulator on Friday said it had made the world's largest seizure of illegal weight loss ...

"UK regulators seize illegal weight loss drugs amid global pricing shake-up" was originally created and published by ...

Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks Jim Cramer recently answered questions about. Answering a caller’s ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Prescription-drug costs were the top-cited factor for rising premiums, according to large businesses surveyed by the think tank. Two-thirds of large businesses said GLP-1s for weight loss had a ...

Eli Lilly ( NYSE: LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in ...

Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

Novo Nordisk faces a challenge in tapping into the U.S. mass market for weight-loss drugs. With new board leadership, the ...